However, some studies showed that the subclinical inflammation was recognized as a key feature of the atherosclerotic process [44], and several markers of subclinical inflammation, such as C-reactive protein (CRP) and interleukin-6 (IL-6), were associated with an increased risk of coronary artery disease [45,46]. The gene discussed is CRP; the disease is coronary artery disorder.